Antibody-drug conjugate targeting glypican-1 inhibits tumor growth and tumor angiogenesis for glypican-1 positive cholangiocarcinoma.

被引：0
|
作者：
Yokota, Keiichiro [1 ]
Serada, Satoshi [1 ]
Tsujii, Shigehiro [1 ]
Murakami, Ichiro [1 ]
Hanazaki, Kazuhiro [1 ]
Naka, Tetsuji [1 ]
机构：
[1] Kochi Med Sch, Nankoku, Kochi, Japan
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1315
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antibody-drug conjugate targeting glypican-1 shows tumor growth inhibition in cholangiocarcinoma
    Yokota, Keiichiro
    Serada, Satoshi
    Tsujii, Shigehiro
    Hiramatsu, Kosuke
    Namikawa, Tsutomu
    Murakami, Ichiro
    Hanazaki, Kazuhiro
    Naka, Tetsuji
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Antibody-drug conjugate targeting glypican-1 shows potent antitumor effect in pancreatic cancer
    Serada, Satoshi
    Nishigaki, Takahiko
    Sugase, Takahito
    Saito, Yurina
    Takahashi, Tsuyoshi
    Hiramatsu, Kosuke
    Fujimoto, Minoru
    Mori, Masaki
    Doki, Yuichiro
    Naka, Tetsuji
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma
    Yokota, Keiichiro
    Serada, Satoshi
    Tsujii, Shigehiro
    Toya, Keisuke
    Takahashi, Tsuyoshi
    Matsunaga, Takashi
    Fujimoto, Minoru
    Uemura, Sunao
    Namikawa, Tsutomu
    Murakami, Ichiro
    Kobayashi, Shogo
    Eguchi, Hidetoshi
    Doki, Yuichiro
    Hanazaki, Kazuhiro
    Naka, Tetsuji
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1713 - 1722
  • [4] Glypican-1-targeted antibody-drug conjugate inhibits the growth of glypican-1-positive glioblastoma
    Uchida, Shun
    Serada, Satoshi
    Suzuki, Yuji
    Funajima, Eiji
    Kitakami, Kei
    Dobashi, Kazumasa
    Tamatani, Satomi
    Sato, Yuichi
    Beppu, Takaaki
    Ogasawara, Kuniaki
    Naka, Testuji
    NEOPLASIA, 2024, 50
  • [5] Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer
    Matsuzaki, Satoko
    Serada, Satoshi
    Hiramatsu, Kosuke
    Nojima, Satoshi
    Matsuzaki, Shinya
    Ueda, Yutaka
    Ohkawara, Tomoharu
    Mabuchi, Seiji
    Fujimoto, Minoru
    Morii, Eiichi
    Yoshino, Kiyoshi
    Kimura, Tadashi
    Naka, Tetsuji
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (05) : 1056 - 1066
  • [6] Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer
    Tsujii, Shigehiro
    Serada, Satoshi
    Fujimoto, Minoru
    Uemura, Sunao
    Namikawa, Tsutomu
    Nomura, Taisei
    Murakami, Ichiro
    Hanazaki, Kazuhiro
    Naka, Tetsuji
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2495 - 2505
  • [7] Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth
    Nhat D. Quach
    Sukhneeraj Pal Kaur
    Matthew W. Eggert
    Lishann Ingram
    Deepraj Ghosh
    Sheela Sheth
    Tamas Nagy
    Michelle R. Dawson
    Robert D. Arnold
    Brian S. Cummings
    Scientific Reports, 9
  • [8] Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth
    Quach, Nhat D.
    Kaur, Sukhneeraj Pal
    Eggert, Matthew W.
    Ingram, Lishann
    Ghosh, Deepraj
    Sheth, Sheela
    Nagy, Tamas
    Dawson, Michelle R.
    Arnold, Robert D.
    Cummings, Brian S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Surface glycocalyx and glypican-1 mediate tumor cell metastasis
    Qazi, Henry
    Moran, Heriberto
    Cancel, Limary M.
    Mayer, Mariya
    Roberge, Sylvie
    Huang, Peigen
    Munn, Lance L.
    Tarbell, John M.
    FASEB JOURNAL, 2018, 32 (01):
  • [10] The Glypican-1/c-Met and Glypican-1/Vascular Endothelial Growth Factor Receptor 2 complexes regulate hair follicle angiogenesis
    Colin-Pierre, Charlie
    Berthelemy, Nicolas
    Belloy, Nicolas
    Danoux, Louis
    Bardey, Vincent
    Rivet, Romain
    Mine, Solene
    Maquart, Francois-Xavier
    Ramont, Laurent
    Brezillon, Stephane
    WOUND REPAIR AND REGENERATION, 2022, 30 (05) : A17 - A18
12345